Cannabis Use Permits Sample Clauses

Cannabis Use Permits. Tenant acknowledges and agrees and Landlord requires, that Tenant shall secure all State of Colorado and all County of Cxxxxxx, Colorado required licenses and approvals of all applicable jurisdictions and regulatory bodies, including those required under the Marijuana Code, Title 44, Article 10, Section 101 et. seq. and any and all applicable rules, and regulations promulgated pursuant thereto, as such may be amended or substituted from time to time (the “Marijuana Code”) to operate for its intended medical marijuana cultivation facility, and any other permitted use per Tenant’s permit, including without limitation, those necessary to be in compliance with the Marijuana Code (collectively, the “Cannabis Use Permits”). Tenant shall evidence all such Cannabis Use Permits by providing a copy of same to Landlord. Tenant covenants and agrees that during the Term of this Lease Tenant shall use its best efforts to keep all such Cannabis Use Permits in full force and effect with the State of Colorado at that time and to materially comply with all applicable laws, rules and regulations including the Marijuana Code.
Sample 1Sample 2Sample 3See All (11)
AutoNDA by SimpleDocs
Cannabis Use Permits. Tenant acknowledges and agrees and Landlord requires, that Tenant shall secure all State of Colorado and all County of Cxxxxxx Colorado required licenses and approvals of all applicable jurisdictions and regulatory bodies, including those required under the Marijuana Code, Title 44, Article 11, Section 101 et. seq. (the “MMC”) as well as the Colorado Constitution, Article XVIII, those promulgated by the Colorado Department of Regulatory Agencies and the Denver Department of Excise and Licenses to operate for its intended medical marijuana grow and/or process facility, and any other permitted use per Tenant’s permit, including without limitation, those necessary to be in compliance with all State of Colorado regulations noted in the MMC (collectively, the “Cannabis Use Permits”). Tenant shall evidence all such Cannabis Use Permits by providing a copy of same to Landlord along with a letter from Tenant’s legal counsel enclosing same and confirming that those enclosures represent all State of Colorado required approvals or permits that are available to evidence to a Landlord; and shall advise Landlord that Tenant has secured such Cannabis Use Permits and is at such time in compliance with same, and that all such Cannabis Use Permits remain in full force and effect with the State of Colorado at that time. As of the Effective Date the parties acknowledge that rules, regulations and requirements of the State of Colorado pertaining to the intended use hereunder include those described at the website for the State of Colorado’s “Medical Marijuana Code”, hxxxx://xxx.xxxxxxxx.xxx/xxxxxxx/enforcement/statues-colorado-revised-statutes-crs; Tenant shall at all times remain in compliance therewith; and such web site refers among other things to the implementation of the Department’s rules for all forms of marijuana, including medical marijuana, overseeing the statewide Medical Marijuana Use Registry, licensing of Colorado businesses to cultivate, process, and dispense marijuana; and among other implementing legislation and regulation, Article 11, Colorado Statutes and Colorado Administrative Code Chapter 44 found in the Department of State Colorado Administrative Register (“CAR”).
Sample 1Sample 2
Cannabis Use Permits. Tenant acknowledges and agrees, and Landlord requires, that Tenant shall secure all State of Oklahoma and all County of Cxxxx, Oklahoma required licenses and approvals of all applicable jurisdictions and regulatory bodies, including those required under State Question 788 (“Marijuana Code”), enforced by the Oklahoma Medical Marijuana Authority (“OMMA”), and any and all applicable rules, and regulations promulgated pursuant thereto, as such may be amended or substituted from time to time (Marijuana Code) to operate for its intended medical marijuana cultivation facility, and any other permitted use per Tenant’s permit, including without limitation, those necessary to be in compliance with the Marijuana Code. Tenant shall evidence all such Cannabis Use Permits by providing a copy of same to Landlord. Tenant covenants and agrees that during the Term of this Lease Tenant shall use its best efforts to keep all such Cannabis Use Permits in full force and effect with the State of Oklahoma at that time and to materially comply with all applicable laws, rules and regulations including the Marijuana Code.
Sample 1
Cannabis Use Permits. Tenant acknowledges and agrees and Landlord requires, that the appropriate Tenant Parties shall secure and maintain all licenses and approvals required by all applicable State and municipal jurisdictions and regulatory bodies, including those required under the Maine Medical Use of Marijuana Act, Title 22, Chapter 558-C, any other Maine laws related to the growth or cultivation of marijuana or cannabis, and any and all applicable rules, and regulations promulgated pursuant thereto, as such may be amended or substituted from time to time, (collectively, the “Marijuana Act”) to allow the appropriate Tenant Parties to operate a marijuana cultivation facility on the Premises, and to perform any other use permitted by the Tenant Parties’ licenses and/or permits, including without limitation, those necessary to be in compliance with the Marijuana Act (collectively, the “Cannabis Use Permits”). Each of the Tenant Parties shall evidence all such Cannabis Use Permits by providing a copy of same to Landlord. Each of the Tenant Parties covenant and agree that during the Term of this Lease, each such Tenant Party shall keep all such Cannabis Use Permits in full force and effect with the State of Maine at that time and to materially comply with all applicable laws, rules and regulations including the Marijuana Act. Judley, LLC and Sagemed, LLC, severally agree, in addition to other necessary licenses and approval, to maintain registrations pursuant to Title 22 Chapter, 558-C. At least one of the Tenant Parties shall maintain a license under the Maine Medical Use of Marijuana Act, Title 22, Chapter 558-C at all times during the Term.
Sample 1
Cannabis Use Permits. Tenant acknowledges and agrees, and Landlord requires, that Tenant shall secure all State of Michigan and all Marengo Township, Michigan required licenses and approvals of all applicable jurisdictions and regulatory bodies, including those required under The Michigan Marijuana Act (“Marijuana Code”), enforced by the Michigan Marijuana Regulatory Agency (“MRA”), a division of the Michigan Department of Licensing and Regulatory Affairs (“LARA”), collectively referred to as “Cannabis Use Permits”, and any and all applicable rules, and regulations promulgated pursuant thereto, as such may be amended or substituted from time to time, to operate for its intended marijuana cultivation facility, and any other permitted use per Tenant’s permit, including without limitation, those necessary to be in compliance with the Marijuana Code. Tenant shall evidence all such Cannabis Use Permits by providing a copy of same to Landlord. Tenant covenants and agrees that during the Term of this Lease Tenant shall use its best efforts to keep all such Cannabis Use Permits in full force and effect with the State of Michigan at that time and to materially comply with all applicable laws, rules and regulations including the Marijuana Code.
Sample 1

Related to Cannabis Use Permits

  • Applicable Permits Written confirmation that all Applicable Permits then required are in full force and effect including a list of such clearances.

  • Compliance; Permits All activity undertaken pursuant to this Contract shall be in compliance with federal and state law and regulations and City Requirements. Developer shall obtain all permits and approvals required to do the work authorized under this Contract.

  • Building Permits All building permits required for the construction of the Improvements have been obtained prior to the commencement of the construction of the Improvements and copies of same will be delivered to Lessor.

  • Permits, Licenses, Etc Each of the Borrower and its Subsidiaries possesses all permits, licenses, patents, patent rights or licenses, trademarks, trademark rights, trade names rights, and copyrights which are material to the conduct of its business. Each of the Borrower and its Subsidiaries manages and operates its business in accordance with all applicable Legal Requirements except where the failure to so manage or operate could not reasonably be expected to result in a Material Adverse Change; provided that this Section 4.14 does not apply with respect to Environmental Permits.

  • Work Permits The Executive shall use his reasonable best efforts to obtain, maintain and renew a suitable (for the purposes of the Executive's contemplated employment by the Company) work permit by the Bermuda government authorities and any other permits required by any Bermuda government authority. The Company shall be responsible for permit fees, and all other expenses, including legal expenses, in connection with obtaining and maintaining such work permit.

  • Regulatory Permits The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate federal, state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the SEC Reports, except where the failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect (“Material Permits”), and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation or modification of any Material Permit.

  • Permits/Licenses Contractor and all Contractor’s employees or agents shall secure and maintain in force such permits and licenses as are required by law in connection with the furnishing of services pursuant to this Contract.

  • Compliance with Laws; Licenses and Permits (a) The Transferred Subsidiaries, the Business, the Business Real Property and, with respect to the Business, Sellers and Controlled Affiliates are, and to the Knowledge of Sellers, the Joint Venture is, and for the past three (3) years have been, in compliance in all material respects with all applicable Laws. (b) Section 2.12(b) of the Seller Disclosure Letter sets forth a true and complete list of all Permits (other than PMAs and DERs) primarily relating to, or used or held for use in the operation or conduct of, or in connection with, the Business as conducted as of the date hereof, including special use or conditional use Permits relating to zoning requirements (collectively, the “Business Permits”) that are material to the Business, and the legal owner of such Business Permits; provided, that all FAA certificates and aviation certificates issued by any foreign equivalent Governmental Authority shall be deemed to be material to the Business for purposes of this Section 2.12(b). The Business Permits set forth in Section 2.12(b) of the Seller Disclosure Schedule represent all material Permits necessary for the lawful conduct of the Business as conducted as of the date hereof. The Business Permits are valid and in full force and effect, neither Sellers, their Controlled Affiliates, nor any of the Transferred Subsidiaries are or have during the past three (3) years been in default under the Business Permits, and no suspension, revocation, cancellation or material modification of any Business Permit is pending or, to the Knowledge of Sellers, has been threatened, except for any default pursuant to any such Business Permit or proceeding to suspend, revoke, cancel or modify any such Business Permit as would not, individually or in the aggregate, be (or reasonably be expected to be) material to the Business, taken as a whole. (c) Since April 1, 2018, none of the Transferred Subsidiaries, the Business or, with respect to the Business, Sellers or any other Controlled Affiliates thereof, any of their respective officers, directors, employees, or, to the Knowledge of Sellers, other representatives or agents, in each case, with respect to the Business, or, to the Knowledge of Sellers, the Joint Venture, has taken any action in violation of the U.S. Foreign Corrupt Practices Act of 1977, the UK Bribery Act 2010, all Laws enacted to implement the OECD Convention on Combating Bribery of Foreign Officials in International Business Transactions and all other applicable Laws relating to bribery, corruption, kick-backs or other improper or unlawful payments (regardless of the form, whether in money, property, services or otherwise) (collectively, “Anti-Corruption and Anti-Bribery Laws”). For purposes of this Section 2.12(c), “Knowledge of the Sellers” means the actual knowledge or awareness of a high probability of the existence of such circumstance, unless the individual actually believes that such circumstance does not exist, as of the Business Day prior to the date hereof, of the individuals set forth on Section 9.1(d) of the Seller Disclosure Letter.

  • PARKING PERMITS A. Must be obtained on the day of move in. B. Towing charges resulting from violations will be the responsibility of the RESIDENT. C. Any form of duplication of parking permits is a violation of the LEASE AGREEMENT, and may be grounds for eviction. Note: Refer to Resident Handbook for further detail.

  • Compliance; Permits; Restrictions (a) The Company and each of its Subsidiaries are, and since January 1, 2019 have been, in compliance in all material respects with all applicable Laws, including the Federal Food, Drug, and Cosmetic Act (“FDCA”), the U.S. Food and Drug Administration (“FDA”) regulations adopted thereunder, the Public Health Service Act and any other similar Law administered or promulgated by the FDA or other comparable Governmental Body responsible for regulation of the development, clinical testing, manufacturing, sale, marketing, distribution and importation or exportation of drug and biopharmaceutical products (each, a “Drug Regulatory Agency”), except for any noncompliance, either individually or in the aggregate, which would not be material to the Company. No investigation, claim, suit, proceeding, audit or other action by any Governmental Body is pending or, to the Company’s Knowledge, threatened against the Company or any of its Subsidiaries. There is no agreement, judgment, injunction, order or decree binding upon the Company or any of its Subsidiaries which (i) has or would reasonably be expected to have the effect of prohibiting or materially impairing any business practice of the Company or any of its Subsidiaries, any acquisition of material property by the Company or any of its Subsidiaries or the conduct of business by the Company or any of its Subsidiaries as currently conducted, (ii) is reasonably likely to have an adverse effect on the Company’s ability to comply with or perform any covenant or obligation under this Agreement, or (iii) is reasonably likely to have the effect of preventing, delaying, making illegal or otherwise interfering with the Contemplated Transactions. Notwithstanding the foregoing, for all purposes of this Agreement, the Company does not make any representation or warranty (pursuant to this Section 2.15 or elsewhere) regarding the effect of any applicable Antitrust Laws on the Company’s ability to execute, deliver or perform its obligations under this Agreement or to consummate the Contemplated Transactions as a result of any enactment, promulgation, application or threatened or actual judicial or administrative investigation or litigation under, or enforcement of, any Antitrust Laws with respect to the consummation of the Contemplated Transactions. (b) The Company and its Subsidiaries hold all required Governmental Authorizations which are material to the operation of the business of the Company and its Subsidiaries as currently conducted (the “Company Permits”). Section 2.15(b) of the Company Disclosure Schedule identifies each Company Permit. The Company and its Subsidiaries hold all right, title and interest in and to all Company Permits free and clear of any Encumbrance. The Company and each of its Subsidiaries is in material compliance with the terms of the Company Permits. No Legal Proceeding is pending or, to the Company’s Knowledge, threatened, which seeks to revoke, limit, suspend, or materially modify any Company Permit. The rights and benefits of each Company Permit will be available to the Surviving Corporation or its Subsidiaries, as applicable, immediately after the Effective Time on terms substantially identical to those enjoyed by the Company and its Subsidiaries as of the date of this Agreement and immediately prior to the Effective Time. (c) There are no proceedings pending or, to the Company’s Knowledge, threatened with respect to an alleged material violation by the Company or any of its Subsidiaries of the FDCA, FDA regulations adopted thereunder, the Public Health Service Act or any other similar Law administered or promulgated by any Drug Regulatory Agency. The Company is not currently conducting or addressing, and to the Company’s Knowledge there is no basis to expect that it will be required to conduct or address, any corrective actions, including, without limitation, product recalls or clinical holds. (d) To the Company’s Knowledge, all clinical, pre-clinical and other studies and tests conducted by or on behalf of, or sponsored by, the Company or its Subsidiaries, or in which the Company or its Subsidiaries or their respective current products or product candidates have participated, were and, if still pending, are being conducted in all material respects in accordance with standard medical and scientific research procedures and in compliance in all material respects with the applicable regulations of any applicable Drug Regulatory Agency and other applicable Law, including 21 C.F.R. Parts 50, 54, 56, 58 and 312. Since January 1, 2019, neither the Company nor any of its Subsidiaries has received any notices, correspondence, or other communications from any Drug Regulatory Agency requiring, or, to the Company’s Knowledge, threatening to initiate, the termination or suspension of any clinical studies conducted by or on behalf of, or sponsored by, the Company or any of its Subsidiaries or in which the Company or any of its Subsidiaries or their respective current products or product candidates have participated. (e) Neither the Company nor any of its Subsidiaries is the subject of any pending or, to the Company’s Knowledge, threatened investigation in respect of its business or products by the FDA pursuant to its “Fraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities” Final Policy set forth in 56 Fed. Reg. 46191 (September 10, 1991) and any amendments thereto. To the Company’s Knowledge, neither the Company nor any of its Subsidiaries has committed any acts, made any statement, or failed to make any statement, in each case in respect of its business or products that would violate the FDA’s “Fraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities” Final Policy, and any amendments thereto. None of the Company, any of its Subsidiaries or any of their respective officers, employees or agents has been convicted of any crime or engaged in any conduct that could result in a debarment or exclusion (i) under 21 U.S.C. Section 335a or (ii) any similar applicable Law. No debarment or exclusionary claims, actions, proceedings or investigations in respect of their business or products are pending or, to the Company’s Knowledge, threatened against the Company, any of its Subsidiaries or any of their respective officers, employees or agents.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!